There were 1,732 press releases posted in the last 24 hours and 426,261 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
I-Mab Announces IND Clearance from FDA for TJM2 to Treat Cytokine Release Syndrome (CRS) Associated with Severe Coronavirus Disease 19 (COVID-19)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image